Treatment results with oral Rocaltrol pulse among patients with secondary hyperparathyroidism in hemodialysis ward
Background and Objective: Renal osteodystrophy is one of the most important complications of ESRD (End Stage Renal Disease). Prescription of calcium, low phosphate diet and rocaltrol are essential in these patients. The aim of this study was to determine the prevalence of renal osteodystrophy and se...
Guardado en:
Autores principales: | M Malek, M Fakharian Kashani |
---|---|
Formato: | article |
Lenguaje: | EN FA |
Publicado: |
Babol University of Medical Sciences
2004
|
Materias: | |
Acceso en línea: | https://doaj.org/article/4190f83d774a4994ac2cb7f78b78aeb2 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Pharmacokinetics of evocalcet in secondary hyperparathyroidism patients receiving hemodialysis: first-in-patient clinical trial in Japan
por: Shigematsu T, et al.
Publicado: (2018) -
Epidemiological study of orthopedic injuries in hemodialysis patients in Taiwan: a fixed cohort survey, 2004–2008
por: Chang NT, et al.
Publicado: (2013) -
Experience of surgical treatment of secondary hyperparathyroidism
por: E. A. Ilyicheva, et al.
Publicado: (2016) -
Results of surgical treatment of uremic hyperparathyroidism (analysis 67 observations)
por: E. A. Il'icheva, et al.
Publicado: (2018) -
Disputable Issues of Etiology and Pathogenesis of Tertiary Hyperparathyroidism
por: G. A. Bersenev, et al.
Publicado: (2019)